Physician profile
James R Bollinger
NPI 1336156785
$6,003.10
in general payments reported to CMS, 2019-2025
35 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $623 · 2021: $1,313 · 2022: $1,086 · 2023: $663 · 2024: $896 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,582 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,581.90 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,188.10 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $910.50 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Sumitomo Pharma America, INC. | $711.72 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $509.14 | 2019-2024 | |
| Tolmar, INC. | $483.75 | 2023-2025 | Eligard, Jatenzo |
| Myovant Sciences INC. | $413.13 | 2021-2022 | |
| Abbvie INC. | $211.35 | 2019-2024 | |
| Boston Scientific Corporation | $190.50 | 2019-2025 | Ams 700 |
| Myriad Genetic Laboratories, INC. | $179.94 | 2020-2024 | Prolaris |
| Acerus Pharmaceuticals Corporation | $143.71 | 2020-2022 | |
| Antares Pharma, INC. | $135.73 | 2020-2022 | |
| Procept Biorobotics Corporation | $103.92 | 2025 | |
| Clarus Therapeutics INC. | $93.77 | 2021 | |
| Halozyme INC | $81.35 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.89 | 2021-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $62.20 | 2025 | Azmiro |
| Verity Pharmaceuticals INC. | $51.98 | 2025 | Tlando |
| Palette Life Sciences, INC. | $47.22 | 2023 | |
| Laborie Medical Technologies Corp. | $43.65 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Blue Earth Diagnostics | $41.08 | 2021-2022 | |
| Urogen Pharma, INC. | $40.27 | 2023-2024 | Jelmyto |
| Coloplast Corp | $38.99 | 2021-2022 | |
| Vibrant Gastro, INC. | $35.00 | 2025 | Vibrant Starter Kit |
| Axonics, INC. | $30.90 | 2023-2024 | Axonics |
| Ferring Pharmaceuticals INC. | $21.20 | 2025 | Adstiladrin |
| Telix Pharmaceuticals | $21.20 | 2024 | Illuccix |
| 180 Medical, INC. | $21.20 | 2023 | |
| Immunitybio, INC. | $18.10 | 2024 | |
| Janssen Pharmaceuticals, INC | $17.13 | 2019-2021 | |
| Mission Pharmacal Company | $16.48 | 2020 | |
| Urovant Sciences INC | $15.52 | 2022 | |
| Alexion Pharmaceuticals, INC. | $14.35 | 2019 | |
| Medtronic, INC. | $13.33 | 2023 | Interstim |
| Olympus America INC. | $12.99 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bollinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.